VYANT BIO INC (VYNT) Stock Balance Sheet
NASDAQ:VYNT - Nasdaq - US92942V2088 - Common Stock - Currency: USD
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 10.04M | 20.61M | 2.44M | 3.88M | 160.00K | |||
| Receivables | 323.00K | 434.00K | 870.00K | 2.33M | 780.00K | |||
| Inventories | 53.00K | 475.00K | N/A | N/A | N/A | |||
| Other Current Assets | 1.09M | 1.70M | 800.00K | 970.00K | 23.52M | |||
| Total Current Assets | 11.51M | 23.21M | 4.11M | 7.18M | 24.46M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.65M | 1.69M | 700.00K | 650.00K | 560.00K | |||
| Investments And Advances | N/A | N/A | 0.00 | 90.00K | 90.00K | |||
| Goodwill | N/A | N/A | 2.98M | 3.09M | 5.96M | |||
| Intangibles | N/A | N/A | 0.00 | 2.90M | 3.35M | |||
| Other Non-Current Assets | 1.05M | 12.73M | 570.00K | 640.00K | 990.00K | |||
| Total Non-Current Assets | 3.70M | 14.42M | 4.24M | 7.72M | 10.95M | |||
| TOTAL ASSETS | 15.21M | 37.64M | 8.35M | 14.90M | 35.41M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 1.28M | 2.48M | |||
| Current Portion Of LT Debt. | 252.00K | 157.00K | 40.00K | 70.00K | 50.00K | |||
| Accrued Expenses | 1.47M | 938.00K | 220.00K | 190.00K | 0.00 | |||
| Accounts Payable | 655.00K | 740.00K | 2.33M | 2.07M | 4.60M | |||
| Other Current Liabilities | 1.29M | 3.60M | 1.67M | 3.36M | 21.02M | |||
| Total Current Liabilities | 3.67M | 5.43M | 4.26M | 6.97M | 28.15M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 330.00K | 350.00K | 70.00K | 110.00K | 50.00K | |||
| Other Non-Current Liabilities | 1.30M | 565.00K | 30.00K | 440.00K | 400.00K | |||
| Total Non-Current Liabilities | 1.63M | 915.00K | 110.00K | 550.00K | 450.00K | |||
| TOTAL LIABILITIES | 5.30M | 6.35M | 4.37M | 7.52M | 28.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -101.50M | -78.81M | -172.43M | -164.42M | -157.72M | |||
| Additional Paid In Capital | 111.44M | 110.17M | 176.63M | 171.78M | 164.46M | |||
| Common Shares | 1.00K | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -32.00K | -74.00K | -220.00K | 30.00K | 60.00K | |||
| Shares Outstanding | 5.92M | 5.80M | 4.14M | 2.10M | 920.00K | |||
| Tangible Book Value per Share | 1.67 | 5.40 | 0.24 | 0.67 | -2.73 | |||
| Total Shareholders' Equity | 9.91M | 31.29M | 3.98M | 7.39M | 6.80M | |||
| TOTAL LIABILITIES AND EQUITY | 15.21M | 37.64M | 8.35M | 14.90M | 35.41M | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.01 | 0.02 | 0.19 | 0.37 | |||
| Current Ratio | 3.14 | 4.27 | 0.96 | 1.03 | 0.87 | |||
| Return On Assets (ROA) | -149.23% | -108.56% | -95.81% | -45.03% | -57.53% | |||
| Return On Equity (ROE) | -228.98% | -130.58% | -201.01% | -90.80% | -299.56% | |||
All data in USD , ROIC based on taxRate of 0.21